FDA Approves Zoster Vaccine Recombinant Prefilled Syringe Presentation for Shingles Prevention
The FDA approves a prefilled syringe for the zoster vaccine recombinant, enhancing shingles vaccination convenience and effectiveness for adults 50…
Gabapentin Use Linked to Increased Dementia Risk in Chronic Back Pain Patients
New research links gabapentin use for back pain to increased dementia risk, especially in non-elderly adults.
1044: Converting inpatients from insulin glargine 300 units/mL to insulin detemir 100 units/mL without causing hypoglycemia
Show notes at pharmacyjoe.com/episode1044. In this episode, I’ll discuss converting inpatients from insulin glargine 300 units/mL to insulin detemir 100…
GLP-1 and GIP Combination Shows Promise for Weight Loss, Cardiometabolic Improvement in Obesity
Maridebart cafraglutide showed promising results for weight management in obesity and type 2 diabetes (T2D), achieving significant weight loss without…
Does Corticosteroid Use Have a Role in Severe Community-Acquired Pneumonia?
Since the most recent guidelines were published, more evidence has emerged regarding intravenous corticosteroids for severely ill patients.
Secondary Analysis Investigates Spillover Effects of Antibiotic Audit and Feedback
New research shows effective interventions can reduce prescriptions across all ages.
Zanubrutinib Outperforms Acalabrutinib in Adjusted Head-to-Head Analysis
An adjusted analysis of the ALPINE and ASCEND trials revealed a statistically significant progression-free survival advantage for Zanubrutinib.
Flu Vaccines Are a Go
Influenza Vaccination Preparation Should Be on the Docket for Any Pharmacy After a Much-Anticipated ACIP Meeting
Data Show Simvastatin Does Not Enhance Escitalopram Response in Comorbid Depression and Obesity
Statins such as simvastatin do not have additional antidepressive effects in combination with standard escitalopram treatment in patients with comorbid…
Follow-Up Study Confirms Omlyclo Biosimilarity to Xolair in Treatment of CSU
The biosimilar showed similar efficacy, pharmacokinetics, pharmacodynamics, safety, quality of life, and immunogenicity in patients with chronic spontaneous urticaria (CSU).